Page last updated: 2024-12-06

1-nitrobenzo(a)pyrene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

## 1-Nitrobenzo(a)pyrene: A Potent Mutagen and Carcinogen

1-Nitrobenzo(a)pyrene (1-NP) is a potent **mutagenic and carcinogenic** compound derived from **benzo(a)pyrene (BaP)**. BaP is a polycyclic aromatic hydrocarbon (PAH) found in **coal tar, diesel exhaust, cigarette smoke, and charred meat**.

Here's why 1-NP is important for research:

**1. Environmental Carcinogen:** 1-NP is a **highly reactive** molecule that readily forms **DNA adducts** - molecules that bind to DNA and interfere with its function. This leads to mutations and can ultimately cause cancer. 1-NP is considered a major contributor to the carcinogenicity of BaP and is found in significant quantities in **environmental pollutants**. Understanding its properties and behavior is crucial for assessing and mitigating the risks posed by environmental pollution.

**2. Mechanisms of Carcinogenesis:** Research on 1-NP helps us understand the **mechanisms of carcinogenesis** at a molecular level. It allows scientists to study how specific chemicals damage DNA, activate cellular pathways leading to uncontrolled cell growth, and ultimately cause cancer. This knowledge can be used to develop better cancer prevention strategies and treatments.

**3. Bioactivation and Metabolism:** 1-NP is a **pro-carcinogen**, meaning it is not carcinogenic in its original form. It requires **bioactivation** within the body to become carcinogenic. Understanding this bioactivation process is essential for predicting and preventing cancer risk. Studying 1-NP helps researchers unravel the complex pathways involved in **metabolism and detoxification** of PAHs.

**4. Risk Assessment and Remediation:** 1-NP is a key compound for **risk assessment** of PAH exposure. By studying its **toxicological properties** and **distribution in the environment**, researchers can better estimate the health risks associated with exposure to PAHs. This knowledge can guide public health policies and environmental regulations to minimize exposure and protect human health.

**5. Development of Anti-Cancer Therapies:** 1-NP research has led to the development of **anti-cancer drugs** that target specific pathways involved in its carcinogenesis. These drugs can be used to treat or prevent cancer caused by PAH exposure.

**In summary, 1-nitrobenzo(a)pyrene is a potent environmental carcinogen with significant research implications. Understanding its properties and behavior is crucial for evaluating environmental risks, developing cancer prevention strategies, and designing novel anti-cancer therapies.**

Cross-References

ID SourceID
PubMed CID50958
CHEMBL ID164492
MeSH IDM0119868

Synonyms (18)

Synonym
1-nitrobenzo(a)pyrene
ccris 2161
benzo(a)pyrene, 1-nitro-
brn 4322791
CHEMBL164492
1-nitro-benzo[def]chrysene
1-nitrobenzo[a]pyrene
70021-99-7
unii-7lw05phl0k
hsdb 8187
7lw05phl0k ,
nitrobenzo(a)pyrene
70021-42-0
benzo(a)pyrene, nitro-
benzo[a]pyrene, nitro-
nitrobenzo[a]pyrene
DTXSID4075085
nitrobenzo(a)pyrene, 1-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID200690Mutagenic activity in an Ames test on Salmonella Typhimurium TA98; Activity is log of revertants/nmol1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity.
AID23442Partition coefficient (logP)1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (52.63)18.7374
1990's6 (31.58)18.2507
2000's3 (15.79)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.94

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.94 (24.57)
Research Supply Index3.22 (2.92)
Research Growth Index4.16 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.94)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.17%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (95.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]